May 06, 2013|1 min readBy Jeffrey BouleyRockland Immunochemicals acquires antibody line from 21st Century BiochemicalsBiotechnology company Rockland Immunochemicals Inc. has acquired the Epi-Plus antibody product line from 21st Century Biochemicals Inc.
Mar 06, 2014|3 min readBy Jeffrey BouleyRockland Immunochemicals expands facilitiesIn January, company began move into a new 60,000-square-foot space
Feb 14, 2015|3 min readBy Zack AnchorsAdding to the mix Rockland ventures into aptamer market with SBIR funding
Apr 09, 2012|3 min readBy Kelsey KaustinenA rock-solid partnershipRockland, NCI collaboration announces release of new antibodies
Apr 15, 2016|2 min readImproving on CIK CAR-TFormula and Rockland collaborate to develop C.I.K. CAR pipeline for cancer
Jan 06, 2020|2 min readBy Jeffrey BouleyThe first immunotherapy to become first-line treatment for advanced urothelial carcinoma?Bavencio significantly improved overall survival in patients with locally advanced or metastatic urothelial carcinoma
Sep 17, 2014|2 min readBy Kelsey KaustinenEMD Serono teams with Sutro Biopharma for ADCsSutro could receive up to $375 million in milestone payments, in addition to an undisclosed upfront payment
Apr 21, 2013|3 min readBy Jim CiriglianoA rallying point for cancer researchAACR’s Annual Meeting 2013 and Rally for Medical Research draw thousands to nation’s capital
Apr 02, 2014|3 min readBy Kelsey KaustinenTrio unites in lupus agreementEMD Serono, Pfizer and Broad Institute to collaborate on genomic profiling of patients with SLE and LN
Sep 06, 2011|3 min readBy Amy SwindermanTools of the tradeLife science tool providers provide constant support to ever-evolving stem cell research community